At the time of writing, Regenxbio Inc [RGNX] stock is trading at $8.19, up 5.41%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RGNX shares have gain 10.53% over the last week, with a monthly amount drifted -10.59%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On June 07, 2024, Goldman initiated with a Buy rating and assigned a price target of $38 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $36 on March 11, 2024. RBC Capital Mkts upgraded its rating to a Outperform and raised its price target to $35 on March 08, 2024. Leerink Partners upgraded its rating to Outperform for this stock on March 06, 2024, but kept the price target unchanged to $37.
For the past year, the stock price of Regenxbio Inc fluctuated between $7.14 and $28.80. Currently, Wall Street analysts expect the stock to reach $26.33 within the next 12 months. Regenxbio Inc [NASDAQ: RGNX] shares were valued at $8.19 at the most recent close of the market. An investor can expect a potential return of 221.49% based on the average RGNX price forecast.
Analyzing the RGNX fundamentals
According to Regenxbio Inc [NASDAQ:RGNX], the company’s sales were 84.33M for trailing twelve months, which represents an -16.31% plunge. Gross Profit Margin for this corporation currently stands at 0.39% with Operating Profit Margin at -2.89%, Pretax Profit Margin comes in at -2.83%, and Net Profit Margin reading is -2.83%. To continue investigating profitability, this company’s Return on Assets is posted at -0.46, Equity is -0.71 and Total Capital is -0.59.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.90 points at the first support level, and at 7.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.49, and for the 2nd resistance point, it is at 8.78.
Ratios To Look Out For
It is important to note that Regenxbio Inc [NASDAQ:RGNX] has a current ratio of 3.05. Further, the Quick Ratio stands at 3.05, while the Cash Ratio is 0.55. Considering the valuation of this stock, the price to sales ratio is 4.76, the price to book ratio is 1.35.
Transactions by insiders
Recent insider trading involved VITTAL VASISTA, Officer, that happened on Dec 30 ’24 when 20041.0 shares were purchased. Director, KARABELAS ARGERIS N completed a deal on Oct 01 ’24 to sell 10000.0 shares. Meanwhile, Director KARABELAS ARGERIS N sold 10000.0 shares on Sep 03 ’24.
